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i Summary: C-reactive protein and elastase-c^-proteinase inhibitor complexes were compared in the diagnosis of
j neonatal sepsis and bacterial infections in adults on the intensive care unit. Both analytes were measured in the
1
 same sample immediately after receipt.
EDTA-plasma samples (n = 115) from 28 neonates (gestational age 29—42 weeks) within the first 72 hours of life
with suspected neonatal sepsis, 2 babies between 14 and 28 days old with B-streptococcus infections and 28 adults
on the intensive care unit with positive bacterial cultures were analysed for both analytes. Two adults with long-
term infections were followed up over a period of 28 and 65 days respectively.
The results showed that in 17 cases of confirmed neonatal sepsis within the first 24 hours of life, c-reactive protein
levels were undetectable in 16 cases, one level of 13 mg/1 being recorded. All had elevated elastase-arproteinase
inhibitor concentrations. Of the remaining 15 samples, 13 were normal and 2 were borderline for this analyte. C-
reactive protein levels were between 5 and 10 mg/1 in 5 cases and undectable in the remaining 10 samples. Those
neonates with detectable c-reactive protein levels were between 20 and 72 hours old with a gestational age greater
than 31 weeks. C-reactive protein was undetectable in samples taken at the same time interval after birth from fiill-
terms babies with a gestational age of 41—42 weeks, even in confirmed cases of neonatal sepsis.
In adults, 64/68 samples showed both elevated c-reactive protein and elevated elastase-ai-proteinase inhibitor, the
remaining 4 samples being elevated for c-reactive protein and normal for elastase-arproteinase inhibitor. Three of
these four patients had a pronounced leukopenia. Although the diagnostic value of a single determination of either
analyte was sufficient and similar m both cases, the time coiirse of each was different during the course of illness
and treatment, so that the cörrelation between c-reactive protein and elastase-arproteinase inhibitor, although
statistically significant (p = 0.01) was relatively low (r = 0.312, n = 115).
From the results it can be shown that the analyte of choice for neonatal sepsis within the first 3 days of life is
elastase-cti-proteinase inhibitor. In older infants and adults, c-reactive protein is preferable, äs it is quicker to
determine, can be perförmed in most clinical chemistry laboratories and is of similar diagnostic value.
Introduction C-reactive protein belongs to the pentraxines, a group of
non-specific defence proteins found in all vertebrates. It
In addition to their widespread use in the diagnosis of
 consists of five identical non-glycosylated subunits of
bacterial infection, e-reactiye protein (1-5) and elas- MT 21 000 and binds to the galactan residues of microor-
tase-arproteinase inhibitor complexes (6—10) also have ganisms causing agglutination and precipitation, fol-
their place in the follow-up of patients. lowed by classical activation of the complement System.
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Increases in serum c-reactive protein are seen within a
few hours after infection.
Elastase is a proteinase secreted from polymorphic neu-
trophils and is neutralised by complexing with arpro-
teinase inhibitor (arantitrypsin), so that its activity is
normally localised at the site of polymorphic neutrophil
interaction with bacteria, usually, but not always, in the
lung. Elastase also complexes with a2-macroglobulin. In
this case, the elastase retains its enzymatic activity, but
is enclosed by the a2-macroglobulin, thus restricting the
active Substrates to those small enough to penetrate into
the complex.
Although many textbooks refer to the usefulness of o
reactive protein in diagnosing bacterial infection (11,
12), it is suiprising to find reference values for newborns
which are higher than those for adults (12). It is known,
that c-reactive protein synthesis in newbora rabbits is
not mature (13), and that serum c-reactive protein levels
in preterm infants with (14) and without (15) infection
increase over the first 48 hours after birth. Several
groups have noted the absence of a c-reactive protein
response in many cases of neonatal sepsis (16—17).
Other groups report the usefulness of c-reactive protein
in diagnosing neonatal sepsis (18-19) even on the first
day after birth.
On the other band, elastase-aj-proteinase inhibitor com-
plexes are suitable for the diagnosis and therapy control
of sepsis at all ages, including neonates (20-22).
Whether this is practicable is discussed below.
Materials and Methods
C-reactive protein was measured using the Behring Turbitimer ne-
phelometric method, according to the manufacturer's instructions.
The reference ränge for healthy adults was less than 6 mg/1. Values
above 10 mg/1 were taken äs elevated.
Elastase-ctj -proteinase inhibitor concentrations were measured by
an immunoluminometric assay äs already pubiished (20). The ref-
erence ränge for healthy adults was 250 g/l, for neonates 200 g/l.
Values above 300 g/l for adults and 250 g/| for neonates were
taken äs elevated. The Standard used was human PMN-elastase
(Protogen, Läufelfingen, Switzerland) complexed with cii-antitryp-
sin (Sigma, Deisenhofen, Germany).
Patients
The patients consisted of 28 neonates (gestational age 29-42
weeks) within the first 3 days of life, 2 babies between 14 and 24
days old and 28 adults from the intensive care unit. Two adults
were studied over a period of one month, during the time they were
in the intensive care unit. The relevant details are given below:
Case l (Figure la)
A 44 year old male was admitted on day 0 with fever and was
treated with broad spectrum antibiotics. On day 11, Candida anti-
bodies were detected in serum, which persisted throughout the ob-
servation period. Between day 14 and day 21, Candida antigen was
positive in tracheal secretion cultures. Between day 18 and 20,
Enterobacter cultures were positive in tracheal secretion: On day
27, Citrobacter, Pseudomonas, and Escherichia coli were found
in tracheal secretion and pleura punctate. Selective therapy was
commenced on the saine day. On day 38, Pseudomonas was again
found in tracheal secretion, a Situation which persisted throughout
the observation period. From day 42,fa severe sepsis developed in
which Staphylococci, Enterococci.Xanthomonas and Enterobacter
persisted. Treatment was continued, the patient recovered slowly,
and he was transferred to a peripheral ward on day 65.
Case 2 (Figure Ib)
A 34 year old woman was admitted to the intensive care unit with
respiratory complications and had to be intubated. On day 5 and
day 17, B-strepiococci were found in lung aspirates. After anti-
biotic treatment no further microbiological problems arose, and the
patient was transferred to a penpheral ward on day 28.
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Fig. l C-reactive protein (H H) and elastase- -proteinase in-
hibitor (ü-D) concentrations in patients with recurrent infections.
The abscissa shows the observation time.-Day l was the day on
which the first plasma sample was taken. Bacterial cultures were
set up from tracheal secretion and pleural punction. The details and
course of disease are given in the text.
a) A 45 year old male patient with recurrent multiple infection.
b) A 34 year old female patient with recurrent B-streptococcus
infection during Intubation». *;
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mal levels being seen in a single case. Seventeen neo-
nates showed elevated values for elastase-arantipro-
teinase, 2 were borderline and 13 showed normal values.
C-reactive protein levels were above 10 mg/1 in one case
(gestational age 40 weeks), between 5 and 10 mg/1 in 5
cases (gestational age 31—40 weeks) and undetectable
in 26 cases (gestational age 29-42 weeks).
Among the neonates, 17 cases of neonatal sepsis were
confirmed, all having elevated elastase-arantiproteinase
levels. The c-reactive protein levels in these cases were
all under 13 mg/1, 16 being under 5 mg/1. The values for
10000 the babies older than 14 days were between 514 and
Elastase-c^-protease Inhibitor [ / ] 275° VS/1 for elastase-arproteinase inhibitor, and be-
tween 50 and 122 mg/1 for c-reactive protein. Both bab-
ies were suffering from B-streptococcus infections.
Discussion
This article compares the rnerits and disadvantages of c-
reactive protein and elastase-arproteinase inhibitor
levels in patients with bacterial infection. Whereas for
adults, both markers were similar in their diagnostic
value, c-reactive protein was not suitable äs a monitor
of neonatal sepsis.
The varying degrees of maturity of the c-reactive protein
synthesis at birth make its diagnostic sensitivity and
specificity so low äs to render the analyte worthless
within the first few days of life, with a real danger that
"normal values" may be seen despite the presence of an
infection. There appeared to be no correlation between
the gestational age and time of appearance of c-reactive
protein in serum after birth. The values from the two
babies with pneumonia showed that c-reactive protein
synthesis was active 14 days after birth. This is in ac-
cqrdance with literature reports that c-reactive protein
synthesis increases steadily after the first 24 hours of
life (15).
Three of the four discrepant cases in figure 2a (elastase-
cti-proteinase inhibitor normal, c-reactive protein elev-
ated) the patients had a pronounced leukopenia, which
could account for the low elastase-arproteinase inhibi-
tor levels. It is known that in prolonged bacterial infec-
tion, the granula secreting elastase become depleted, so
that low concentrations are detected in plasma.
The results presented here indicate the c-reactive protein
is the marker of choice in adults and children, äs it is
not only equal in diagnostic reliability, but also much
cheaper and quicker to analyse. Elastase-cti-proteinase
inhibitor is the marker of choice for diagnosis of neo-
natal sepsis, especially when the samples are taken from
preterm infants within the first days of life. The use of
this marker for adults shows no advantages over c-reac-
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Fig. 2 Elastase-arprotein£se inhibitor and c-reactive protein
levels in samples from adults and newborns.
a) In 69 samples from adults on the intensive care unit with known
bacterial infections. The area denoted by A is the reference ränge
for healthy adults for both analytes. Area B (hatched) shows the
elevated values for both analytes.
b) In newborns with the tentative diagnosis of neonatal sepsis. The
values in area A were normal in both assays and corresponded to
those newborns without neonatal sepsis. All other cases had neona-
tal sepsis and, with one exception, were misclassified (false nega-
tive results) by the c-reactive protein assay. The hatehed area (B)
shows the elevated results for both analytes.
The upper limits of the reference ränge are shown for adults for c-
reactive protein, and for newborns for elastase-arproteinase inhib-
itor.
Results
Figures l a and Ib show the twp time courses of the
cases described above. Figure 2a shows the distribution
of c-reactive protein and elastase values in adults, and
figure 2b in newborns, measured within the first 36
hours of life.
In the adults, elevated elastase^-proteinase inhibitor
levels were found in 52 cases, borderline concentrations
in 10 cases and normal values in 5 cases. Elevated c-
reactive protein levels were observed in 66 cases, nor-
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tive protein and therefore can be replaced by the latter
to confirm the diagnosis. The time course of both ana-
lytes can be quite difFerent äs shown in figures l a (partly
discordant) and Ib (füll concordance) and is reflected
by the low correlation coefficient between the two ana-
lytes of r = 0.313 (n = 115, p = 0.01).
The markers reflect two different responses, one by the
liver, the other by the leukocytes. It may be interesting
to study both markers during the course of the disease
in children and adults. The main purpose of the present
communication, however, was to consider the diagnostic
reliability of single measurem^nts of both markers.
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